EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Directionally aligned nanofibrous polycaprolactone/gelatin scaffolds as durable scleral implants for long‐term ocular reconstruction

Ikhyun Jun iD, Seungmin Kang, Taehyeon Kim iD, Youngbin Seo iD, Hae-Sol Shin iD, Sejin Myeong, David Myung, Kyoung Yul Seo iD, Won-Gun Koh iD

Bioengineering & Translational Medicine · 10.11.2026

DOI: 10.1002/btm2.70196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 10.11.2026. Verfasst von Ikhyun Jun und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Vision Research, Department of Ophthalmology Yonsei University College of Medicine Seoul South Korea. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scleral defects caused by pathological conditions or surgical complications remain a major challenge in ophthalmology owing to the lack of durable implantable materials. In this study, we developed electrospun polycaprolactone/gelatin (PCL/GE) nanofibrous scaffolds with controlled fiber orientation for long‐term scleral reconstruction. Three scaffold architectures—random, radially aligned, and uniaxially aligned—were fabricated and benchmarked against Ologen™, a clinically used collagen matrix. The scaffolds exhibited an average fiber diameter of approximately 1 μm, high porosity (96.3%–96.9%), and tensile properties comparable to those reported for native rabbit and human sclera. In vitro, anisotropic scaffolds significantly enhanced fibroblast proliferation, directional organization, and collagen type I production compared with random scaffolds. Following enzymatic degradation for 6 weeks, the PCL/GE scaffolds retained approximately 77% of their initial mass, compared with approximately 70% for Ologen™. In a rabbit scleral defect model, anisotropic scaffolds promoted smoother surface healing and reduced peri‐implant inflammation at 6 weeks without significant changes in intraocular pressure or pro‐inflammatory cytokine expression. At 24 weeks, all PCL/GE scaffolds remained structurally intact, whereas Ologen™ had completely degraded, resulting in choroidal exposure. Histological analysis further revealed that the radially aligned scaffold produced the thinnest fibrotic capsule and more favorable tissue integration than the random scaffold. These findings demonstrate that electrospun PCL/GE nanofibrous scaffolds provide mechanical compatibility, long‐term structural stability, and excellent biocompatibility, highlighting their potential as durable implants for scleral reconstruction.

Schlagwörter

Stichwörter der Autor:innen

aligned PCL/gelatin fiberelectrospun fiberfiber orientationscleral implant

Autor:innen und Institutionen

  • The Institute of Vision Research, Department of Ophthalmology Yonsei University College of Medicine Seoul South Korea.
  • The Corneal Dystrophy Research Institute, Department of Ophthalmology Yonsei University College of Medicine Seoul South Korea.
  • Department of Chemical and Biomolecular Engineering Yonsei University Seoul South Korea.
  • Spencer Center for Vision Research, Byers Eye Institute, Department of Ophthalmology Stanford University Palo Alto California USA.
  • Department of Chemical Engineering Stanford University Stanford California USA.

ORCID-Profile: Ikhyun Jun, Taehyeon Kim, Youngbin Seo, Hae-Sol Shin, Kyoung Yul Seo, Won-Gun Koh

Förderung

  • NEI NIH HHS
  • National Research Foundation of Korea

Zitieren

APA

Jun, I., Kang, S., Kim, T., Seo, Y., Shin, H. S., Myeong, S., Myung, D., Seo, K. Y., & Koh, W. G. (2026). Directionally aligned nanofibrous polycaprolactone/gelatin scaffolds as durable scleral implants for long‐term ocular reconstruction. Bioengineering & Translational Medicine. https://doi.org/10.1002/btm2.70196

Vancouver

Jun I, Kang S, Kim T, Seo Y, Shin HS, Myeong S, et al. Directionally aligned nanofibrous polycaprolactone/gelatin scaffolds as durable scleral implants for long‐term ocular reconstruction. Bioengineering & Translational Medicine. 2026. doi:10.1002/btm2.70196

BibTeX
@article{Jun2026,
  author = {Jun, Ikhyun and Kang, Seungmin and Kim, Taehyeon and Seo, Youngbin and Shin, Hae-Sol and Myeong, Sejin and Myung, David and Seo, Kyoung Yul and Koh, Won-Gun},
  title = {Directionally aligned nanofibrous polycaprolactone/gelatin scaffolds as durable scleral implants for long‐term ocular reconstruction},
  journal = {Bioengineering & Translational Medicine},
  year = {2026},
  doi = {10.1002/btm2.70196}
}
Kostenlos starten →